Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Phase I Study to Evaluate the Safety and Toxicity of the Combination of Zidovudine and 2',3'-Dideoxyinosine (Didanosine) in Children With HIV Infection

This study has been completed.
Information provided by:
National Institute of Allergy and Infectious Diseases (NIAID) Identifier:
First received: November 2, 1999
Last updated: October 31, 2012
Last verified: October 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 1995
  Estimated Primary Completion Date: No date given